Archives   ::   Issue 32, October 2008     

Cancer RCE Official Opening

The Cancer Research Centre of Excellence (RCE) was officially opened on Wednesday 15 October 2008 by the Guest-of-Honour Mrs Tan Ching Yee, Permanent Secretary, Ministry of Education.

rce

The Cancer RCE aims to take an integrated approach in studying cancers which are endemic to Asian population, such as colorectal cancer, breast cancer and leukaemia. It will fast-track cancer research transforming basic science into treatments for patients. [READ MORE]

Roundtable Discussion on Genomics and Population Health

round

The Roundtable Discussion on Genomics and Population Health was held from 17 to 20 October 2008 at the Vista, University Hall, NUS.

It was organised by the Life Sciences Institute Centre for Molecular Epidemiology (CME), National University of Singapore, Scripps Genomic Medicine Program, San Diego, California, USA and Dunedin Multidisciplinary Health and Development Research Unit, University of Otago, New Zealand. [READ MORE]

CeLS Safety News

box

Suggestion boxes have been placed near the fireman’s lift on each floor of the CeLS building. We have received your invaluable feedback on safety, facilities and scientific matters. Please continue to keep the suggestions coming in as we jointly work towards making CeLS a better place to work in.

Grant Award from Gates Foundation

tongyw

Dr Tong Yen Wah, Assistant Professor with the Department of Chemical and Biomolecular Engineering and the Division of Bioengineering has received a US$100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation.

The grant will support his innovative global health research project, entitled “Molecularly imprinted polymeric nanoparticles to capture viruses in treating infectious diseases – A synthetic antibody”. [READ MORE]

Research Achievement

soong

A/Prof Prof Soong Tuck Wah with the Neurobiology Programme has published a paper in the journal Molecular Pharmacology entitled “Activation of corticotropin releasing factor receptor 1 selectively inhibits CaV3.2 T type calcium channels.”

To read more on this, please click here.